Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jounce Therapeutics Inc (NQ: JNCE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 3, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jounce Therapeutics Inc < Previous 1 2 3 Next > 4 Analysts Have This to Say About Jounce Therapeutics May 23, 2022 Jounce Therapeutics (NASDAQ:JNCE) has observed the following analyst ratings within the last quarter: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022 May 11, 2022 Upgrades Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 May 06, 2022 Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading... Via Benzinga Jounce Therapeutics: Q1 Earnings Insights May 05, 2022 Jounce Therapeutics (NASDAQ:JNCE) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO August 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga 92 Biggest Movers From Friday May 09, 2022 Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety 55 Stocks Moving In Friday's Mid-Day Session May 06, 2022 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. Via Benzinga Jounce Therapeutics Q1 2022 Earnings Conference Call On May 5, 2022 At 08:00 AM ET May 03, 2022 Jounce Therapeutics (NASDAQ:JNCE) will host a conference call at 08:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022 March 16, 2022 Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to... Via Benzinga The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi March 02, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label... Via Benzinga Recap: Jounce Therapeutics Q4 Earnings March 02, 2022 Jounce Therapeutics (NASDAQ:JNCE) reported its Q4 earnings results on Wednesday, March 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.... Via Benzinga Earnings Outlook For Jounce Therapeutics March 01, 2022 Jounce Therapeutics (NASDAQ:JNCE) is set to give its latest quarterly earnings report on Wednesday, 2022-03-02. Here's what investors need to know before the announcement.... Via Benzinga Jounce Therapeutics, inc (JNCE) Q3 2021 Earnings Call Transcript November 06, 2021 JNCE earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 21, 2021 Gainers Viridian Therapeutics (NASDAQ:VRDN) shares rose 18.05% to $12.62 during Tuesday's pre-market session. The company's market cap stands at $120.9 million.... Via Benzinga Earnings Scheduled For March 2, 2022 March 02, 2022 Companies Reporting Before The Bell • SIGNA Sports United (NYSE:SSU) is expected to report quarterly loss at $0.04 per share on revenue of $283.61 million. •... Via Benzinga The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 46 Biggest Movers From Yesterday September 15, 2021 Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited... Via Benzinga The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga 36 Stocks Moving In Tuesday's Mid-Day Session September 14, 2021 Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares... Via Benzinga Jounce Therapeutics, inc (JNCE) Q2 2021 Earnings Call Transcript August 05, 2021 JNCE earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Why Jounce Therapeutics Bounced Higher Today June 15, 2021 The company gets a regulatory nod that will put $25 million in its pocket. Via The Motley Fool Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session June 15, 2021 Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021 September 14, 2021 Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ... Via Benzinga Jounce Therapeutics Stock Is Trading After $25M In Milestone Payment From Gilead June 15, 2021 The FDA has signed off Jounce Therapeutics Inc's (NASDAQ: JNCE) Investigational New Drug (IND) application for JTX-1811, triggering a milestone payment of $25... Via Benzinga Exposures Product Safety Jounce Therapeutics, Inc. (JNCE) Q1 2021 Earnings Call Transcript May 04, 2021 JNCE earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes May 31, 2021 After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... Via Benzinga Exposures Product Safety 3 Buy-Rated Biotech Stocks Under $10 April 20, 2021 The biotech industry has been at the center of investor attention over the past year thanks to the COVID-19 pandemic and an accompanying global race for a vaccine. Via Talk Markets Exposures COVID-19 The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data May 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.